Federal Court Dismisses U. of Rochester's Suit That Sought Billions for Patent Infringement

The University of Rochester's bid to win billions of dollars in a patent-infringement lawsuit against the sellers of the arthritis drug Celebrex has been derailed by a federal judge's ruling that the university's patent is invalid.

Concurring with arguments by the Pharmacia Corporation and Pfizer Inc. in a hearing last July, Judge David G. Larimer of the U.S. district court in Rochester ruled this month that the university's patent was not specific enough, and ordered the suit

Digital or Print Subscription

Already have an account? Log In Now.